Dr Sekimoto, a specialist in Lymphangioleiomyomatosis (LAM), will be conducting research at the UCD Conway Institute.
In October 2022, Dr Yasuhito Sekimoto (MD, PhD) joined a research team led by Assoc. Prof. Cormac McCarthy and Prof. Michael Keane at the UCD Conway Institute. Dr Sekimoto successfully applied for the DevelopMed Fellowship Program (Marie Skłodowska-Curie COFUND Action), which is a Precision Oncology Fellowship at UCD, with the aim of continuing basic research in Lymphangioleiomyomatosis (LAM).
Dr Sekimoto graduated from Juntendo University’s Faculty of Medicine in March 2011. Subsequently he practiced as a pulmonary physician and worked on LAM with the Cystic lung disease research team. He received a PhD from the university's Graduate School in March 2020. His primary research theme is: the role of circulating serum exosomes in epithelial-to-mesenchymal transition and the pre-metastatic niche in lymphangioleiomyomatosis. He will conduct research in UCD for the coming three years.